Diabetes Mellitus and Insulin Management Quiz

Family history increases susceptibility to type 2 diabetes.

Type 1 diabetes is characterized by a lack of insulin production or its ineffectiveness.

Insulin facilitates the uptake of glucose by cells in the body.

Insulin glargine is a long-acting insulin analog used in diabetes management.

Peripheral numbness is a common symptom of diabetic neuropathy.

Glucose is the primary source of energy for cells in the body.

Glucagon's role is to increase blood glucose levels in the body.

GDM involves elevated blood sugar levels during pregnancy.

The pancreas produces insulin, crucial in diabetes regulation.

Tremors are a common symptom of hypoglycemia.

Metformin improves insulin sensitivity in type 2 diabetes.

Maintaining HbA1c levels between 6-7% is the target for diabetes management per ADA.

Hypoglycemia is a common acute complication of insulin therapy.

GDM often resolves after pregnancy but raises the risk of developing type 2 diabetes later.

Diabetic retinopathy involves abnormal blood vessel growth in the retina.

Carbohydrate counting helps match insulin dose with carbohydrate intake in diabetes management.

Insulin glulisine is a rapid-acting insulin analog.

The primary goal of diabetes management is to achieve normal blood glucose levels.

Blood glucose levels determine insulin dosage in type 1 diabetes.

Obesity is a factor contributing to insulin resistance in diabetes.

Sulfonylureas stimulate insulin secretion from pancreatic beta cells in diabetes treatment.

SGLT2 inhibitors block glucose reabsorption in the kidneys, aiding diabetes management.

Glucagon opposes insulin, increasing blood glucose levels.

Diabetic neuropathy is associated with damage to nerves controlling digestion.

Sudden, severe elevation of blood sugar in type 1 diabetes is termed ketoacidosis.